Clinical Trials Directory

Trials / Terminated

TerminatedNCT01410136

Chondrofix Osteochondral Allograft Prospective Study

A Post Market Study to Evaluate the Chondrofix® Osteochondral Allograft Utilized for Treatment of Subjects With Cartilage Lesions in the Knee

Status
Terminated
Phase
N/A
Study type
Interventional
Enrollment
29 (actual)
Sponsor
Zimmer Orthobiologics, Inc. · Industry
Sex
All
Age
18 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The overall study objective is to evaluate Chondrofix Osteochondral Allograft ("Chondrofix") for the repair of osteochondral lesions in the knee. This includes, but is not limited to primary cartilage lesion repair and revision of failed prior cartilage repair treatments. The study hypothesis is that Chondrofix Allograft will provide pain relief and functional improvement as demonstrated by a comparative analysis of baseline clinical evaluations at 24 months of follow-up.

Detailed description

Knee cartilage injuries are a major cause of pain and functional impairment in young to middle age adults and can lead to progressive joint degeneration. In response to challenges with current cartilage repair options, Chondrofix Allograft was developed as an off-the-shelf treatment option adding to the variety of cartilage reparation offerings. This study is a multicenter, prospective, post-market clinical outcomes study designed to assess the clinical outcomes of Chondrofix Allograft used in the treatment of both primary and revision cartilage repair cases. Study design includes up to 6 qualified investigational sites with 50 subjects enrolled across all centers during an 18 month enrollment period. Study subjects will be followed postoperatively for 5 years. The Investigators who are responsible for the conduct of this study in compliance with this protocol will be orthopedic surgeons who are skilled in the techniques of articular cartilage repair.

Conditions

Interventions

TypeNameDescription
PROCEDUREChondrofix Osteochondral AllograftAllogeneic, cylindrical, decellularized, osteochondral graft composed of hyaline cartilage and bone

Timeline

Start date
2011-04-01
Primary completion
2014-03-01
Completion
2014-03-01
First posted
2011-08-04
Last updated
2014-08-11

Locations

5 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT01410136. Inclusion in this directory is not an endorsement.